Clinically relevant,
heavily validated,
widely published.
A colorectal cancer classification system that associates cellular phenotype and responses to therapy – Nature Medicine, 2013
The consensus molecular subtypes (CMS) of colorectal cancer – Nature Medicine, 2015
Analytical Validation of Multiplex Biomarker Assay to stratify Colorectal Cancer into Molecular subtypes – Nature Scientific Reports, 2019
Intratumoral Transcriptome Heterogeneity Is Associated With Patient Prognosis and Sidedness in Patients With Colorectal Cancer Treated With Anti-EGFR Therapy From the CO.20 Trial - JCO Precision Oncology, 2020
Prognostic and predictive impact of consensus molecular subtypes and CRCAssigner classifications in metastatic colorectal cancer- a translational analysis of the TRIBE2 study – ESMO Open, 2021
A seven-Gene Signature assay improves prognostic risk stratification of perioperative chemotherapy treated gastroesophageal cancer patients from the MAGIC trial
A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics – Cancer Discovery, 2015
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours – Gut, 2021
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy – Nature Medicine, 2011
Uridine-derived ribose fuels glucose-restricted pancreatic cancer – Nature Medicine, 2023​










